Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Rogliani

Showing results (1-10 of 461) with videos related to

Pageof 47
Sort By:
Pulmonary Pharmacology & Therapeutics|August 21, 2024
Ensifentrine approval: A milestone in the treatment of COPDLuigino Calzetta, Paola Rogliani
The European Respiratory Journal|January 18, 2024
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutionsJosuel Ora, Paola Rogliani
BMJ Evidence-Based Medicine|June 29, 2018
Tiotropium could provide benefits in the early stage of COPD, but further studies are neededMario Cazzola, Paola Rogliani
Evidence-Based Medicine|August 13, 2017
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV <sub></sub> than long-acting beta-agonists plus inhaled corticosteroidsMario Cazzola, Paola Rogliani
Advances in Therapy|June 22, 2022
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"Luigino Calzetta, Paola Rogliani
American Journal of Respiratory and Critical Care Medicine|November 20, 2024
Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I ErrorLuigino Calzetta, Paola Rogliani
The Journal of Allergy and Clinical Immunology|July 4, 2016
Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?Mario Cazzola, Paola Rogliani
The Lancet. Respiratory Medicine|November 29, 2025
Efficacy of tezepelumab in reducing oral corticosteroid use in severe asthmaPaola Rogliani, Luigino Calzetta
Evidence-Based Medicine|September 17, 2016
LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patientsMario Cazzola, Paola Rogliani
Journal of Comparative Effectiveness Research|August 26, 2017
Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani
Pageof 47

Showing results (1-10 of 461) with videos related to

Sort By:
Pageof 47
Pulmonary Pharmacology & Therapeutics|August 21, 2024
Ensifentrine approval: A milestone in the treatment of COPDLuigino Calzetta, Paola Rogliani
The European Respiratory Journal|January 18, 2024
Clinical challenges in applying the new lung function test interpretive strategies: navigating pitfalls and possible solutionsJosuel Ora, Paola Rogliani
BMJ Evidence-Based Medicine|June 29, 2018
Tiotropium could provide benefits in the early stage of COPD, but further studies are neededMario Cazzola, Paola Rogliani
Evidence-Based Medicine|August 13, 2017
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV <sub></sub> than long-acting beta-agonists plus inhaled corticosteroidsMario Cazzola, Paola Rogliani
Advances in Therapy|June 22, 2022
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"Luigino Calzetta, Paola Rogliani
American Journal of Respiratory and Critical Care Medicine|November 20, 2024
Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I ErrorLuigino Calzetta, Paola Rogliani
The Journal of Allergy and Clinical Immunology|July 4, 2016
Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?Mario Cazzola, Paola Rogliani
The Lancet. Respiratory Medicine|November 29, 2025
Efficacy of tezepelumab in reducing oral corticosteroid use in severe asthmaPaola Rogliani, Luigino Calzetta
Evidence-Based Medicine|September 17, 2016
LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patientsMario Cazzola, Paola Rogliani
Journal of Comparative Effectiveness Research|August 26, 2017
Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani
Pageof 47